Drug Approval | August 31, 2023
Lupin receives USFDA approval for Pirfenidone Capsules
Pirfenidone Capsules had estimated annual sales of USD 95 million in the US
Pirfenidone Capsules had estimated annual sales of USD 95 million in the US
Prasugrel tablets are indicated to reduce the rate of thrombotic CV events
Propranolol LA is a generic equivalent of Inderal LA
Topiramate is the generic version of Supernus Pharmaceuticals’ Trokendi XR
This product will be manufactured at Lupin's Pithampur facility in India
Zinc Sulfate Injection is indicated in adult and paediatric patients as a source of zinc for parenteral nutrition
The drug will be manufactured at JB Pharma's formulation manufacturing facility in Panoli, Gujarat
Guaifenesin extended-release tablets help to loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
Aurobindo's product is already filed with the Drugs Controller General of India (DCGI) and is expected to be approved soon
Doxycycline Hyclate Delayed-Release Tablets USP (RLD Doryx ) had estimated annual sales of USD 9 million in the U.S. (IQVIA MAT June 2023).
Subscribe To Our Newsletter & Stay Updated
